275 related articles for article (PubMed ID: 25986588)
21. Small angle neutron scattering studies on the internal structure of poly(lactide-co-glycolide)-block-poly(ethylene glycol) nanoparticles as drug delivery vehicles.
Yang B; Lowe JP; Schweins R; Edler KJ
Biomacromolecules; 2015 Feb; 16(2):457-64. PubMed ID: 25539145
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.
Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320
[TBL] [Abstract][Full Text] [Related]
23. Surface-Engineered Mucus Penetrating Nucleic Acid Delivery Systems with Cell Penetrating Peptides for the Lungs.
Kumari A; Pal S; G BR; Mohny FP; Gupta N; Miglani C; Pattnaik B; Pal A; Ganguli M
Mol Pharm; 2022 May; 19(5):1309-1324. PubMed ID: 35333535
[TBL] [Abstract][Full Text] [Related]
24. Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-
Yu T; Wang YY; Yang M; Schneider C; Zhong W; Pulicare S; Choi WJ; Mert O; Fu J; Lai SK; Hanes J
Drug Deliv Transl Res; 2012 Apr; 2(2):. PubMed ID: 24205449
[TBL] [Abstract][Full Text] [Related]
25. Interactions of mussel-inspired polymeric nanoparticles with gastric mucin: Implications for gastro-retentive drug delivery.
Sunoqrot S; Hasan L; Alsadi A; Hamed R; Tarawneh O
Colloids Surf B Biointerfaces; 2017 Aug; 156():1-8. PubMed ID: 28499200
[TBL] [Abstract][Full Text] [Related]
26. Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications.
Mazzarino L; Travelet C; Ortega-Murillo S; Otsuka I; Pignot-Paintrand I; Lemos-Senna E; Borsali R
J Colloid Interface Sci; 2012 Mar; 370(1):58-66. PubMed ID: 22284577
[TBL] [Abstract][Full Text] [Related]
27. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
28. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
29. Mucus as a barrier to drug delivery – understanding and mimicking the barrier properties.
Boegh M; Nielsen HM
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):179-86. PubMed ID: 25349046
[TBL] [Abstract][Full Text] [Related]
30. A novel method for modifying AFM probe to investigate the interaction between biomaterial polymers (chitosan-coated PLGA) and mucin film.
Li D; Yamamoto H; Takeuchi H; Kawashima Y
Eur J Pharm Biopharm; 2010 Jun; 75(2):277-83. PubMed ID: 20188826
[TBL] [Abstract][Full Text] [Related]
31. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
Falamarzian A; Lavasanifar A
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
[TBL] [Abstract][Full Text] [Related]
32. Biomimetic mucin modified PLGA nanoparticles for enhanced blood compatibility.
Thasneem YM; Rekha MR; Sajeesh S; Sharma CP
J Colloid Interface Sci; 2013 Nov; 409():237-44. PubMed ID: 23978287
[TBL] [Abstract][Full Text] [Related]
33. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier.
Tang BC; Dawson M; Lai SK; Wang YY; Suk JS; Yang M; Zeitlin P; Boyle MP; Fu J; Hanes J
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19268-73. PubMed ID: 19901335
[TBL] [Abstract][Full Text] [Related]
34. Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles.
Pereira de Sousa I; Steiner C; Schmutzler M; Wilcox MD; Veldhuis GJ; Pearson JP; Huck CW; Salvenmoser W; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):273-9. PubMed ID: 25576256
[TBL] [Abstract][Full Text] [Related]
35. Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells.
Mura S; Hillaireau H; Nicolas J; Kerdine-Römer S; Le Droumaguet B; Deloménie C; Nicolas V; Pallardy M; Tsapis N; Fattal E
Biomacromolecules; 2011 Nov; 12(11):4136-43. PubMed ID: 21981120
[TBL] [Abstract][Full Text] [Related]
36. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
[TBL] [Abstract][Full Text] [Related]
37. Nanoparticle passage through porcine jejunal mucus: Microfluidics and rheology.
Bhattacharjee S; Mahon E; Harrison SM; McGetrick J; Muniyappa M; Carrington SD; Brayden DJ
Nanomedicine; 2017 Apr; 13(3):863-873. PubMed ID: 27965167
[TBL] [Abstract][Full Text] [Related]
38. The effect of nanoparticle permeation on the bulk rheological properties of mucus from the small intestine.
Wilcox MD; Van Rooij LK; Chater PI; Pereira de Sousa I; Pearson JP
Eur J Pharm Biopharm; 2015 Oct; 96():484-7. PubMed ID: 25758122
[TBL] [Abstract][Full Text] [Related]
39. Folate-decorated PEG-PLGA nanoparticles with silica shells for capecitabine controlled and targeted delivery.
Wei K; Peng X; Zou F
Int J Pharm; 2014 Apr; 464(1-2):225-33. PubMed ID: 24463073
[TBL] [Abstract][Full Text] [Related]
40. Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.
Lai SK; Suk JS; Pace A; Wang YY; Yang M; Mert O; Chen J; Kim J; Hanes J
Biomaterials; 2011 Sep; 32(26):6285-90. PubMed ID: 21665271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
